Skip to main content
Livermore
Livermore
ZHEN

Marshall Wace, LLP

SEC CIK
0001318757
Latest filing
Aug 13, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
344,361
Value
$31.2M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EW by Marshall Wace, LLP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026344,361$31.2M<0.1%−1,652,016−82.8%ReducedHolders
Q1 20261,996,377$159.9M0.2%−3,929,250−66.3%ReducedHolders
Q4 20255,925,627$505.2M0.5%+2,359,128+66.1%AddedHolders
Q3 20253,566,499$277.4M0.3%−3,329,080−48.3%ReducedHolders
Q2 20256,895,579$539.3M0.6%+3,864,908+127.5%AddedHolders
Q1 20253,030,671$219.7M0.3%−2,782,748−47.9%ReducedHolders
Q4 20245,813,419$430.4M0.5%+2,079,642+55.7%AddedHolders
Q3 20243,733,777$246.4M0.3%+3,659,111+4,900.6%AddedHolders
Q2 202474,666$6.90M<0.1%−104,328−58.3%ReducedHolders
Q1 2024178,994$17.1M<0.1%+75,973+73.7%AddedHolders
Q4 2023103,021$7.86M<0.1%−1,682,776−94.2%ReducedHolders
Q3 20231,785,797$123.7M0.3%−2,777,940−60.9%ReducedHolders
Q2 20234,563,737$430.5M0.9%−402,059−8.1%ReducedHolders
Q1 20234,965,796$410.8M1.0%+811,769+19.5%AddedHolders
Q4 20224,154,027$309.9M0.8%+641,715+18.3%AddedHolders
Q3 20223,512,312$290.2M0.7%+2,199,410+167.5%AddedHolders
Q2 20221,312,902$124.8M0.3%+883,380+205.7%AddedHolders
Q1 2022429,522$50.6M0.1%+248,806+137.7%AddedHolders
Q4 2021180,716$23.4M<0.1%+171,005+1,760.9%AddedHolders
Q3 20219,711$1.10M<0.1%−17,904−64.8%ReducedHolders
Q2 202127,615$2.86M<0.1%−67,905−71.1%ReducedHolders
Q1 202195,520$7.99M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.